growth of the global sarcopenia treatment market is driven by rise in geriatric population and their adoption of vitamins and dietary supplements for improved treatment of this illness. Furthermore, rise in investments in production of drugs and supplements for the treatment of sarcopenia are expected to boost growth of the sarcopenia treatment market.